Imagine picking up the Wall Street Journal one morning and seeing a write-up about FDA violations that occurred on your conference's show floor. It's not a far-fetched scenario — it happened to the American Society of Clinical Oncology, the American Urological Association, and the American Society of Health-System Pharmacists this summer after a crackdown on exhibitors by the FDA's Division of Drug Marketing, Advertising, and Communications. DDMAC enforces FDA rules regarding pharmaceutical ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.